Published in Cancer Weekly, December 13th, 2005
"Forodesine (Fodosine), a PNP Inhibitor Active in Relapsed or Refractory T-Cell Leukemia Patients (phase II Study) (R. Furman et al.) was presented by Richard R. Furman of Cornell University, during the Poster Session. The poster includes an analysis of the phase II trial data demonstrating that intravenous...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.